Company
ChinaShenzhen Haibin Pharmaceutical Co., Ltd. Off-site Workshop 6, China – FDA Inspections
Inspection records and compliance data for Shenzhen Haibin Pharmaceutical Co., Ltd. Off-site Workshop 6. 1 FDA inspection on record, 1 Form 483, last inspected June 16, 2026.
Company Profile
This profile covers Shenzhen Haibin Pharmaceutical Co., Ltd. Off-site Workshop 6 based in China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected June 16, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 16, 2026 | Not classified | Human Drugs | 1328294 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Shenyang Sunshine Pharmaceutical Co., Ltd.
Shandong Jincheng Bio-Pharmaceutical Co.Ltd
Zibo Xinhua Perrigo Pharmaceutical Co., Ltd.
Huatai Biopharm Inc.
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Yidu Huayang Chemical Co., Ltd (Zhicheng Factory)
Jiangsu Weiqida Pharmaceutical Co., Ltd.
Chongqing Sintaho Pharmaceutical Co., Ltd.
Fujian Nanping Green Pine Chemical Co. Ltd.
Hangzhou Hotide Biotech Co Ltd
Company Information
Name
Shenzhen Haibin Pharmaceutical Co., Ltd. Off-site Workshop 6
FEI Number
3041598181
Address
China
Country
China
ID: 8f7aa635-998f-4331-b118-5d71ab76527e